Restructure Information

Purdue Pharma’s bankruptcy case was heard before the Supreme Court of the United States in December 2023. In June 2024, the Court voted 5-4 against third-party releases contained in the Plan of Reorganization. The decision does nothing to deter us from the twin goals of using settlement dollars for opioid abatement and turning the company into an engine for good. Purdue continues to work tirelessly with creditors to reach a new settlement that delivers billions of dollars of value for opioid abatement and allows the Company to emerge from bankruptcy as a company with a public-minded mission. The Supreme Court’s decision does not affect Purdue’s operational stability or our ability to produce medications safely and effectively. We continue to operate fully, honoring our existing relationships and meeting our obligations to our partners and customers. The company will continue serving patients who rely on our medicines, and working to introduce new medicines that will help save and improve lives.
Click here to learn more

patient-first approach in developing medicines

LEARN MORE

Here to Answer Your Questions

LEARN MORE

The Things We Care About

LEARN MORE

JOIN OUR TEAM

LEARN MORE

Committed to Supporting Compassionate Care

LEARN MORE

RECENT NEWS

Study Examining Use of Nalmefene HCI Injection for Opioid Overdose Reversal in Emergency Departments Concludes Observational Period

STAMFORD, Conn., Sept. 30, 2024 – Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED)…

FDA Approves Zurnai™ (nalmefene injection) Auto-Injector for the Emergency Treatment of Known or Suspected Opioid Overdose Induced by Natural or Synthetic Opioids in Adults and Pediatric Patients 12 Years and Older

STAMFORD, Conn., August 7, 2024 – Purdue Pharma L.P. (“Purdue”) announced today that the U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the Zurnai™…
MORE NEWS
featured-image_OSU-01

Nikki’s House: Supporting Women in Recovery

In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives.

Read More
featured-image_Roby-01

Move Together, Heal Together

Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?”

Read More
featured-image_ORII-hands-01

Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children

Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose.

Read More
×

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.